VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90 | -35.3% | 5,835 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $139 | +9.4% | 5,835 | +16.4% | 0.00% | 0.0% |
| Q1 2023 | $127 | -26.2% | 5,011 | -14.7% | 0.00% | -50.0% |
| Q4 2022 | $172 | -99.8% | 5,874 | +48.1% | 0.00% | +100.0% |
| Q3 2022 | $81,000 | +80.0% | 3,967 | +2.8% | 0.00% | – |
| Q2 2022 | $45,000 | – | 3,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |